National Institutes of Health: Macular Degeneration trials
The registry lists 56 Macular Degeneration studies with National Institutes of Health as lead sponsor. 2 are open to participants now and 8 have results posted.
Early Phase 1 2Phase 1 10Phase 2 9Phase 3 10No phase 27(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- National Eye Institute Biorepository for Retinal DiseasesRecruitingNCT01496625
- Cell Collection to Study Eye DiseasesRecruitingNCT01432847
- Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark AdaptationCompletedNCT03478878Early Phase 1Results posted
- Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark AdaptationCompletedNCT03478865Early Phase 1Results posted
- Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated With Age-Related Macular DegenerationCompletedNCT02564978Phase 2Results posted
- Sirolimus for Advanced Age-Related Macular DegenerationCompletedNCT01445548Phase 1/2Results posted
- Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMDCompletedNCT00766649Phase 1/2Results posted
- Age-Related Eye Disease Study 2 (AREDS2)CompletedNCT00345176Phase 3Results posted
- OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular DegenerationCompletedNCT00306488Phase 2Results posted
- Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular DegenerationCompletedNCT00304954Phase 2Results posted
- Generation of Induced Pluripotent Stem (iPS) Cell Lines From Skin Fibroblast Cells of Participants With Age-Related Macular DegenerationCompletedNCT03372746
- Dark Adaptation in Participants With Age-Related Macular DegenerationCompletedNCT03225131
- AMD Ryan Initiative Study (ARIS)CompletedNCT03092492
- Natural History of Geographic Atrophy Associated With Age-Related Macular DegenerationCompletedNCT02941263
- Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198TerminatedNCT02226835
- The Focal Electro-Oculogram in Macular DiseaseCompletedNCT02225119
- Study of the Effects of Supplements on Eye Disease in Participants From the Age-Related Eye Disease StudyCompletedNCT01915238
- AMD Phenotype and Genotype StudyCompletedNCT01778491
- Blood and Saliva Sample Collection for AREDS 2CompletedNCT01553474
- Study of Dark Adaptation in Age-Related Macular DegenerationCompletedNCT01352975
- Palomid 529 in Patients With Neovascular Age-Related Macular DegenerationCompletedNCT01271270Phase 1
- High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular DegenerationCompletedNCT00656903
- Genetics and Markers of Degenerative and Inflammatory Eye DiseasesCompletedNCT00647439
- Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or RanibizumabCompletedNCT00605943
- Age-Related Eye Disease Study (AREDS) Follow-UpActive, not recruitingNCT00594672
- Potential Research Participants for Future Studies of Inherited Eye DiseasesCompletedNCT00559234
- Effects of Sun Filters on Age-related Macular Degeneration in People With Lens ImplantsWithdrawnNCT00487838
- TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular DegenerationTerminatedNCT00464347Phase 2
- Metabolic Mapping to Measure Retinal MetabolismCompletedNCT00385333Phase 2
- Repository for Inherited Eye DiseasesCompletedNCT00378742
- Genetic Study of Age-Related Macular DegenerationCompletedNCT00357578
- Investigating Age-Related Macular DegenerationCompletedNCT00342251
- Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60CompletedNCT00121589Phase 1
- Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal DisordersCompletedNCT00101764Phase 1
- Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular DegenerationCompletedNCT00100009Phase 3
- Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel DisordersCompletedNCT00071227Phase 1
- Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular DystrophyCompletedNCT00060749Phase 1
- Genetic Factors in Age-Related Macular DegenerationTerminatedNCT00058695
- Clinical and Genetic Studies of X-Linked Juvenile RetinoschisisCompletedNCT00055029
- Laser and Medical Treatment of Diabetic Macular EdemaCompletedNCT00050479Phase 3
- Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic TherapyCompletedNCT00043680Phase 2
- Identification and Treatment of Feeder Vessels in Macular DegenerationCompletedNCT00018070Phase 1
- Fluocinolone Implant to Treat Macular DegenerationCompletedNCT00008515Phase 1
- Lutein for Age-Related Macular DegenerationCompletedNCT00006202Phase 2
- Screening for Studies on Retinovascular DiseasesCompletedNCT00001733
- Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular DegenerationCompletedNCT00001615Phase 1
- Long Term Follow-Up of Diabetic RetinopathyCompletedNCT00001395
- Diabetic Retinopathy and Visual Function StudyCompletedNCT00001346
- Tissue Studies of Human Eye DiseasesTerminatedNCT00001310
- Complications of Age-Related Macular Degeneration Prevention TrialCompletedNCT00000167Phase 3
- Branch Vein Occlusion StudyCompletedNCT00000162Phase 3
- Randomized Trials of Vitamin Supplements and Eye DiseaseStatus unknownNCT00000161Phase 3
- Macular Photocoagulation Study (MPS)Status unknownNCT00000158Phase 3
- Randomized Trial of Beta-Carotene and Macular DegenerationStatus unknownNCT00000152Phase 3
- Submacular Surgery Trials (SST)CompletedNCT00000150Phase 3
- Age-Related Eye Disease Study (AREDS)CompletedNCT00000145Phase 3